Pirfenidone for the Reduction of Metabolic, Inflammatory and Fibrogenic Activity in Complicated Silicosis

Clinical trial NCT05118256 · UNKNOWN

Trial details

NCT number: NCT05118256
Sponsor: Instituto de investigación e innovación biomédica de Cádiz
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Silicosis Progressive Massive Fibrosis Complicated Silicosis

Start date: 2021-11-15
Primary completion: 2022-11-15
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.